Thus, in principle, increasing the abundance or DNA binding ability of partially functional MeCP2 proteins should reduce the severity of RTT (Lamonica et al. 2017) in most cases, except those caused by mutations that lead to total loss of function. Here, MECP2 is linked to Rett syndrome.